Login to Your Account



Clinic Roundup


Tuesday, February 8, 2011
Human Genome Sciences Inc., of Rockville, Md., and GlaxoSmithKline plc, of London, said data from the pivotal BLISS-52 study of Benlysta (belimumab) in autoantibody-positive patients with active systemic lupus erythematosus was published in The Lancet. Data from that study, the first of two positive pivotal trials, originally were reported in 2009.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription